We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Howard Hughes
HHH
$3.93B
| $408K | ﹤0.01% |
+5,426
| New | +$364K |
|
1552
Mid-America Apartment Communities
MAA
$15.5B
| $408K | ﹤0.01% |
+3,222
| New | +$398K |
|
1553
Expro Ltd
XPRO
$1.78B
| $408K | ﹤0.01% |
24,837
-11,038
| -31% | -$144K |
|
1554
Agnico Eagle Mines
AEM
$73B
| $407K | ﹤0.01% |
+5,769
| New | +$430K |
|
|
CORR
1555
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $407K | ﹤0.01% |
+59,352
| New | +$359K |
|
1556
CNB Financial Corp
CCNE
$1.02B
| $406K | ﹤0.01% |
19,055
+552
| +3% | +$10.6K |
|
|
CAJ
1557
DELISTED
Canon, Inc.
CAJ
| $405K | ﹤0.01% |
+20,866
| New | +$377K |
|
|
CLR
1558
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $405K | ﹤0.01% |
+24,820
| New | +$371K |
|
1559
Regenxbio
RGNX
$622M
| $404K | ﹤0.01% |
+8,903
| New | +$311K |
|
1560
Sonoco
SON
$5.8B
| $402K | ﹤0.01% |
+6,792
| New | +$382K |
|
|
RVLP
1561
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $402K | ﹤0.01% |
97,565
-190,132
| -66% | -$1.1M |
|
1562
Newmont
NEM
$98.5B
| $401K | ﹤0.01% |
6,689
-125,904
| -95% | -$7.76M |
|
1563
Brighthouse Financial
BHF
$3.63B
| $400K | ﹤0.01% |
+11,053
| New | +$371K |
|
1564
Peabody Energy
BTU
$2.81B
| $400K | ﹤0.01% |
+165,982
| New | +$269K |
|
1565
Axalta
AXTA
$7.22B
| $399K | ﹤0.01% |
13,963
-269,974
| -95% | -$7.35M |
|
1566
NBT Bancorp
NBTB
$2.73B
| $398K | ﹤0.01% |
+12,388
| New | +$371K |
|
1567
iShares 20+ Year Treasury Bond ETF
TLT
$42.8B
| $398K | ﹤0.01% |
2,526
-71,771
| -97% | -$11.4M |
|
1568
PROG Holdings
PRG
$1.73B
| $397K | ﹤0.01% |
+7,371
| New | +$380K |
|
1569
Tandem Diabetes Care
TNDM
$1.18B
| $397K | ﹤0.01% |
4,149
-9,184
| -69% | -$946K |
|
1570
Criteo
CRTO
$1.05B
| $396K | ﹤0.01% |
19,322
-8,063
| -29% | -$135K |
|
1571
Rayonier Advanced Materials
RYAM
$573M
| $396K | ﹤0.01% |
+60,668
| New | +$322K |
|
1572
HUB Group
HUBG
$2.93B
| $393K | ﹤0.01% |
13,774
-96,020
| -87% | -$2.6M |
|
|
OIIM
1573
DELISTED
02Micro International
OIIM
| $393K | ﹤0.01% |
+42,823
| New | +$278K |
|
|
NBLX
1574
DELISTED
Noble Midstream Partners LP
NBLX
| $393K | ﹤0.01% |
+37,738
| New | +$350K |
|
|
CBMG
1575
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $392K | ﹤0.01% |
21,315
-47,057
| -69% | -$858K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.